Two Sigma Investments, LP Cellectis S.A. Transaction History

Two Sigma Investments, LP

$41.1 Billion
Q2 2024

A detailed history of Two Sigma Investments, LP transactions in Cellectis S.A. stock. As of the latest transaction made, Two Sigma Investments, LP holds 40,289 shares of CLLS stock, worth $85,412. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,289

Previous 49,880 19.23%

Holding current value

$85,412

Previous $132,000 43.18%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.86 - $3.35 $17,839 - $32,129	-9,591 Reduced 19.23%	40,289 $75,000
Q1 2024 May 15, 2024	SELL	$2.41 - $3.09 $5,704 - $7,314	-2,367 Reduced 4.53%	49,880 $132,000
Q4 2023 Feb 14, 2024	BUY	$0.97 - $3.55 $50,679 - $185,476	52,247 New	52,247 $160,000
Q3 2022 Nov 14, 2022	BUY	$2.29 - $4.08 $30,463 - $54,276	13,303 New	13,303 $30,000
Q2 2022 Aug 15, 2022	SELL	$2.39 - $4.93 $315,116 - $650,010	-131,848 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.45 - $8.77 $454,875 - $1.16 Million	131,848 New	131,848 $599,000
Q3 2021 Nov 15, 2021	SELL	$11.94 - $16.09 $266,906 - $359,675	-22,354 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$14.36 - $20.93 $343,017 - $499,954	-23,887 Reduced 51.66%	22,354 $346,000
Q1 2021 May 17, 2021	BUY	$18.19 - $33.25 $287,511 - $525,549	15,806 Added 51.93%	46,241 $935,000
Q4 2020 Feb 16, 2021	BUY	$15.87 - $31.64 $483,003 - $962,963	30,435 New	30,435 $824,000
Q3 2020 Nov 16, 2020	SELL	$15.7 - $20.84 $686,058 - $910,666	-43,698 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.21 - $21.02 $358,760 - $918,531	43,698 New	43,698 $778,000
Q3 2019 Nov 14, 2019	SELL	$10.15 - $16.89 $412,891 - $687,068	-40,679 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$14.6 - $20.6 $593,913 - $837,987	40,679 New	40,679 $635,000
Q1 2019 May 15, 2019	SELL	$15.53 - $19.75 $167,599 - $213,142	-10,792 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$15.58 - $28.41 $168,139 - $306,600	10,792 New	10,792 $180,000

Others Institutions Holding CLLS

# of Institutions

Shares Held

11.2M

Call Options Held

2.8K

Put Options Held

17.9K

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $96.5M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Cellectis S.A. Transaction History